Shaperon Inc.
Clinical-stage biotech developing immune therapeutics for inflammatory diseases.
378800 | KO
Overview
Corporate Details
- ISIN(s):
- KR7378800007
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 자곡로 174-10 강남에이스타워 606호(자곡동), 서울특별시
- Website:
- https://www.shaperon.com/
- Sector:
- Manufacturing
Description
Shaperon Inc. is a clinical-stage biotechnology company that develops novel immune therapeutics for inflammatory diseases. The company's primary focus is on the development of innovative inflammasome inhibitors. Its core technology is based on a unique mechanism that modulates the GPCR19-P2X7 pathway to regulate the initiation and progression of inflammatory responses. This approach is applied to a pipeline of drug candidates targeting various inflammation-driven conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-02-15 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.1 KB | ||
| 2024-01-10 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.3 KB | ||
| 2024-01-10 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 76.7 KB | ||
| 2023-12-14 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2023-11-14 00:00 |
분기보고서 (2023.09)
|
Korean | 1.4 MB | ||
| 2023-10-31 00:00 |
임시주주총회결과
|
Korean | 6.8 KB | ||
| 2023-10-31 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 8.4 KB | ||
| 2023-10-16 00:00 |
주주총회소집공고
|
Korean | 58.1 KB | ||
| 2023-09-21 00:00 |
[기재정정]주주명부폐쇄기간또는기준일설정
|
Korean | 7.4 KB | ||
| 2023-09-11 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2023-09-11 00:00 |
주주총회소집결의(임시주주총회)
|
Korean | 8.5 KB | ||
| 2023-09-07 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청등결정)(경증 또는 중등증 아토피 피부염 환자를 대상으로 HY209겔의 제2상 임상시험계획승인(IND…
|
Korean | 12.1 KB | ||
| 2023-08-14 00:00 |
반기보고서 (2023.06)
|
Korean | 1010.9 KB | ||
| 2023-07-31 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청)(경증 또는 중등증 아토피 피부염 환자를 대상으로 HY209겔의 제2상 임상시험계획승인신청(IND))
|
Korean | 8.7 KB | ||
| 2023-07-18 00:00 |
투자판단관련주요경영사항(임상시험결과)(COVID-19 폐렴 환자를 대상으로 NuSepin® 정맥주입의 유효성 및 안전성 평가를 위한 무작위배정…
|
Korean | 15.5 KB |
Automate Your Workflow. Get a real-time feed of all Shaperon Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Shaperon Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Shaperon Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
